Misdiagnosis of cystic fibrosis — Experience from Germany

作者: Lutz Naehrlich , Azadeh Bagheri-Behrouzi

DOI: 10.1016/J.JCF.2012.06.008

关键词:

摘要: Abstract Background Misdiagnosis of cystic fibrosis (CF) is rare. We investigated patients with misdiagnoses CF in Germany, and compared diagnosed before after 1990. Methods analysed data from the German quality assurance project rechecked CF-centre directors. Results Between 1989 2004, diagnoses were withdrawn 51 5.79years (median), whose diagnosis was based on nonspecific symptoms between 1979 2001 at median age 4.33years. transmembrane conductance regulator (CFTR) dysfunction indicated by unreliable sweat tests (45.1%), pathologic chloride (37.3%), genetic (3.9%), nasal potential difference measurements (13.1%). Patients 1990 older (6.13 vs 1.21years), more frequently fulfilled diagnostic criteria (77.4% 20%) experienced respiratory (83.9% 50%). Conclusions To detect CF, CF-centres should re-evaluate atypical courses new or transferred patients.

参考文章(32)
Steven M. Rowe, John Paul Clancy, Michael Wilschanski, Nasal Potential Difference Measurements to Assess CFTR Ion Channel Activity Methods in Molecular Biology. ,vol. 741, pp. 69- 86 ,(2011) , 10.1007/978-1-61779-117-8_6
Carmen Casaulta, Martin H Schöni, Jürg Barben, Renate Spinas, Sweat testing practice in Swiss hospitals. Swiss Medical Weekly. ,vol. 137, pp. 192- 198 ,(2007) , 10.4414/SMW.2007.11719
Hakan Yiğit, Mukadder Ayşe Selimoğlu, Sevin Altinkaynak, Sweat test results in children with primary protein energy malnutrition. Journal of Pediatric Gastroenterology and Nutrition. ,vol. 37, pp. 242- 245 ,(2003) , 10.1097/00005176-200309000-00007
ChristineA. Smalley, D.P. Addy, CharlotteM. Anderson, DOES THAT CHILD REALLY HAVE CYSTIC FIBROSIS The Lancet. ,vol. 312, pp. 415- 417 ,(1978) , 10.1016/S0140-6736(78)91878-0
Sarah Berwouts, Joan T. Gordon, Clark A. Rundell, David E. Barton, Elisabeth Dequeker, Evaluation and use of a synthetic quality control material, included in the European external quality assessment scheme for cystic fibrosis. Human Mutation. ,vol. 29, pp. 1063- 1070 ,(2008) , 10.1002/HUMU.20764
M. Thomas, F. Vermeulen, F. De Baets, K. Desager, E. De Wachter, C. Knoop, P. Lebecque, J.-P Sacré, H. Cuppens, K. De Boeck, 41* Who should be analyzed in a cystic fibrosis registry? Journal of Cystic Fibrosis. ,vol. 10, ,(2011) , 10.1016/S1569-1993(11)60061-1
Vicky A. Legrys, Robert E. Wood, Incidence and implications of false-negative sweat test reports in patients with cystic fibrosis Pediatric Pulmonology. ,vol. 4, pp. 169- 172 ,(1988) , 10.1002/PPUL.1950040309
M. Wilschanski, H. Famini, N. Strauss-Liviatan, J. Rivlin, H. Blau, H. Bibi, L. Bentur, Y. Yahav, H. Springer, M.R. Kramer, A. Klar, A. Ilani, B. Kerem, E. Kerem, Nasal potential difference measurements in patients with atypical cystic fibrosis European Respiratory Journal. ,vol. 17, pp. 1208- 1215 ,(2001) , 10.1183/09031936.01.00092501
J. Coakley, S. Scott, R. Mackay, R. Greaves, L. Jolly, J. Massie, A. Mishra, A. Bransden, J. C G Doery, A. Chiriano, H. Robins, Sweat testing for cystic fibrosis: standards of performance in Australasia Annals of Clinical Biochemistry. ,vol. 46, pp. 332- 337 ,(2009) , 10.1258/ACB.2009.009023
Riordan, J. Rommens, B Kerem, N Alon, R Rozmahel, Z Grzelczak, J Zielenski, S Lok, N Plavsic, J. Chou, al. et, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. ,vol. 245, pp. 1066- 1073 ,(1989) , 10.1126/SCIENCE.2475911